| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT05856851 Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy |
Trial completed |
| 2026-08-13 | NCT05856851 Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy |
date change Primary completion moved earlier: 2025-12 -> 2025-01-15 |
| 2026-08-13 | NCT05856851 Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy |
date change Completion moved earlier: 2025-12 -> 2025-11-01 |
| 2026-08-09 | NCT05412589 mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06533709 Satisfactory Debulking Prediction Model for Advanced Ovarian Cancer Based on PET-CT Image… |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT06523933 Distribution of Bacteria in OME After Radiotherapy For NPC. |
overall status: Active, Not Recruiting → Unknown |
| 2026-08-02 | NCT06510127 An AI Model Predicts the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: a… |
overall status: Enrolling by Invitation → Unknown |
| 2026-08-02 | NCT06505486 GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large… |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT05838001 Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable… |
overall status: Recruiting → Unknown |
| 2026-08-02 | NCT05797454 Efficacy and Accuracy of Combined Localization Versus Single Localization in Non-palpable… |
overall status: Recruiting → Unknown |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-12 | NCT07761325 Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for… | Phase 3 | Not Yet Recruiting |
| 2026-08-07 | NCT07752966 Evaluation of a Genetic Risk Score for Lung Metastasis and Prognosis in Breast Cancer | Not Yet Recruiting | |
| 2026-07-29 | NCT07735169 Clinical Observation of Skin Condition in Patients With Acne Vulgaris Using Ubiquinol… | Not Yet Recruiting | |
| 2026-07-27 | NCT07728955 A Single-arm, Exploratory Clinical Study Evaluating the Efficacy and Safety of… | Phase 3 | Not Yet Recruiting |
| 2026-07-24 | NCT07726407 SGRT in Head and Neck Cancer Radiotherapy | Recruiting | |
| 2026-07-23 | NCT07721935 Development of an AI-Agent for Urological Disease Diagnosis and Treatment | Recruiting | |
| 2026-07-21 | NCT07717242 Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder Cancer | Phase 2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05682131 | South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol | Arsenic Trioxide | Recruiting |
| NCT06641544 | The Efficacy and Safety of Different Combination Regimens of Inetetamab in First-line… | Metastatic Breast Cancer | Recruiting |
| NCT05787509 | Prolonged Progesterone to Prevent Preterm Birth From IVF - ET | Preterm Birth | Recruiting |
| NCT05910125 | Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke | Ischemic Stroke | Not Yet Recruiting |
| NCT06487143 | Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP | Central Precocious Puberty | Not Yet Recruiting |
| Phase 3 | |||
| NCT04646759 | Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer | Breast Cancer | Recruiting |
| NCT05904964 | Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer… | HR Positive/HER2 Low Expression Metastatic Breast Cancer | Recruiting |
| NCT05980715 | PD-1 Inhibitor Therapy Versus Radiotherapy in pCR Patients With Locally Advanced HNSCC… | HNSCC | Recruiting |
| NCT05159193 | Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential… | Breast Cancer | Recruiting |
| NCT06278870 | Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced… | HER2-positive Metastatic Breast Cancer | Recruiting |
| NCT06313463 | Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After… | Breast Neoplasms | Recruiting |
| NCT05582265 | Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in… | Head and Neck Squamous Cell Carcinomas | Recruiting |
| NCT07066280 | Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer | Skin Microbiome | Recruiting |
| NCT06255392 | Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in… | Fludzoparib" and Anti-angiogenic | Recruiting |
| NCT05760612 | Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth… | Early-stage Breast Cancer | Recruiting |
| NCT06172205 | Infusional FOLFOX Plus Camrelizumab and Apatinib vs HAIC-FOLFOX Plus Camrelizumab and… | BCLC Stage C Hepatocellular Carcinoma | Recruiting |
| NCT07092709 | Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users | Acute Ischemic Stroke | Recruiting |
| NCT06966245 | External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia | Mastalgia | Recruiting |
| NCT07137832 | OPtimizing REperfusion by Intra-Arterial ThRomboLysis as Adjunct to Endovascular… | Acute Ischemic Stroke | Recruiting |
| NCT06889688 | Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in… | Breast Cancer Stage IV | Recruiting |
| NCT07400523 | Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual… | Breast Cancer | Recruiting |
| NCT07606807 | rhTNK-tPA for Acute Ischemic Stroke Under Simplified Imaging in the Extended Time Window | Acute Ischemic Stroke | Recruiting |
| NCT06404775 | External Mastalgia-oil Versus Oral Tamoxifen in Premenopausal Women with Severe Mastalgia | Mastalgia | Not Yet Recruiting |
| NCT06364904 | A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab… | Bladder Cancer | Not Yet Recruiting |
| NCT06870448 | Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke | Acute Ischemic Stroke | Not Yet Recruiting |